DSIP
DSIP (delta sleep-inducing peptide) is a nonapeptide first isolated from rabbit brain dialysate in the 1970s that despite its name has shown inconsistent effects on slow-wave (delta) sleep in later controlled human studies, with a more consistent modern research focus on stress, pain, and neuroendocrine modulation.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
What it does & how it works
DSIP's original discovery was tied to electrophysiological induction of delta-wave sleep states in rabbits, and it has since been proposed to modulate the hypothalamic-pituitary-adrenal axis (affecting ACTH/cortisol release), influence opioid and stress-response pathways, and exert antioxidant and neuroprotective actions in later rodent work, including improved motor recovery after experimental stroke. The precise receptor or binding target for DSIP has never been definitively established, which is a key reason its mechanism remains only partially characterized decades after discovery.
Typical results seen in research
Early human studies in the 1980s reported some improvements in subjective and objective sleep parameters in a subset of insomniac and disturbed-sleep patients, but subsequent double-blind controlled trials produced mixed and inconsistent results on actual slow-wave/delta sleep induction, undermining the peptide's namesake claim. More recent research has shifted toward rodent models of stress resilience, pain modulation, and post-stroke recovery rather than confirming a reliable human sleep-architecture effect, so DSIP should not be presented as a reliably sleep-inducing agent based on current evidence.
How it’s commonly used
In the original human sleep studies DSIP was administered by intravenous or intramuscular injection; in contemporary research-chemical use it is typically administered by subcutaneous injection.
- British Journal of Clinical Pharmacology · 1981 The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep
- Neuropsychobiology · 1992 Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study
- Molecules · 2021 Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke
- Life Sciences · 2018 Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.